 |
The Journal of Neuroscience, March 31, 2004, 24(13):3453-3459; doi:10.1523/JNEUROSCI.0297-04.2004
Previous Article
Neurobiology of Disease
Neuronal Zinc Exchange with the Blood Vessel Wall Promotes Cerebral Amyloid Angiopathy in an Animal Model of Alzheimer's Disease
Avi L. Friedlich,1 *
Joo-Yong Lee,2 *
Thomas van Groen,3
Robert A. Cherny,4,5
Irene Volitakis,4,5
Toby B. Cole,6
Richard D. Palmiter,6
Jae-Young Koh,2 and
Ashley I. Bush1,4,5
1Laboratory for Oxidation Biology, Genetics and Aging Research Unit, Massachusetts General Hospital, and Department of Psychiatry, Harvard Medical School, Charlestown, Massachusetts 02129-4404, 2National Creative Research Initiative Center for the Study of CNS Zinc, University of Ulsan College of Medicine, Seoul 138-736, Korea, 3Department of Neuroscience and Neurology, University of Kuopio, Kuopio FIN 70211, Finland, 4Mental Health Research Institute of Victoria, Parkville, Victoria 3052, Australia, 5Department of Pathology, University of Melbourne, Parkville, Victoria 3010, Australia, and 6Howard Hughes Medical Institute, Department of Biochemistry, University of Washington, Seattle, Washington 98195
Cerebral amyloid angiopathy (CAA) is common in Alzheimer's disease (AD) and may contribute to dementia and cerebral hemorrhage. Parenchymal -amyloid deposition is dependent on the activity of zinc transporter 3 (ZnT3), a neocortical synaptic vesicle membrane protein that causes enrichment of exchangeable Zn2+ in the vesicle, which is externalized on neurotransmission. However, the contribution of zinc to vascular -amyloid deposition remains unclear. Here, we identify for the first time an exchangeable pool of Zn2+ in the cerebrovascular wall of normal mice. This histochemically reactive Zn2+ is enriched in CAA in a transgenic mouse model of AD (Tg2576), and a dramatic reduction of CAA occurs after targeted disruption of the Znt3 gene in these mice. Also, in Znt3 knock-out mice, the amount of exchangeable Zn2+ [detected by N-(6-methoxy-8-quinolyl)-p-carboxybenzoylsulphonamide (TFL-Zn)] in the perivascular space was significantly decreased in the neocortex but not in peripheral organs. ZnT3 was not detected in the cerebral vessel walls or in blood components of wild-type mice. Thus, synaptic ZnT3 activity may promote CAA by indirectly raising exchangeable Zn2+ concentrations in the perivascular spaces of the brain.
Key words: Alzheimer; bloodbrain; neuropathology; synapse; zinc; amyloid; cerebrovasculature; congophilic angiopathy
Received Dec 8, 2003;
revised February 20, 2004;
accepted February 21, 2004.
This article has been cited by other articles:

|
 |

|
 |
 
K. W. Leung, M. Liu, X. Xu, M. J. Seiler, C. J. Barnstable, and J. Tombran-Tink
Expression of ZnT and ZIP Zinc Transporters in the Human RPE and Their Regulation by Neurotrophic Factors
Invest. Ophthalmol. Vis. Sci.,
March 1, 2008;
49(3):
1221 - 1231.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. H. Linkous, J. M. Flinn, J. Y. Koh, A. Lanzirotti, P. M. Bertsch, B. F. Jones, L. J. Giblin, and C. J. Frederickson
Evidence That the ZNT3 Protein Controls the Total Amount of Elemental Zinc in Synaptic Vesicles
J. Histochem. Cytochem.,
January 1, 2008;
56(1):
3 - 6.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P Bressler, L. Olivi, J. H. Cheong, Y. Kim, A. Maerten, and D. Bannon
Metal transporters in intestine and brain: their involvement in metal-associated neurotoxicities
Human and Experimental Toxicology,
March 1, 2007;
26(3):
221 - 229.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Religa, D. Strozyk, R. A. Cherny, I. Volitakis, V. Haroutunian, B. Winblad, J. Naslund, and A. I. Bush
Elevated cortical zinc in Alzheimer disease.
Neurology,
July 11, 2006;
67(1):
69 - 75.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|